461 related articles for article (PubMed ID: 11535634)
1. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis.
Huseby ES; Liggitt D; Brabb T; Schnabel B; Ohlén C; Goverman J
J Exp Med; 2001 Sep; 194(5):669-76. PubMed ID: 11535634
[TBL] [Abstract][Full Text] [Related]
2. Inconsistence between number and function of autoreactive T cells in the course of experimental autoimmune encephalomyelitis.
Wan X; Pei W; Zhang Y; Zhang L; Shahzad KA; Xu T; Shen C
Immunol Invest; 2018 Jan; 47(1):1-17. PubMed ID: 28872930
[TBL] [Abstract][Full Text] [Related]
3. MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8⁺ T cells.
Ji Q; Castelli L; Goverman JM
Nat Immunol; 2013 Mar; 14(3):254-61. PubMed ID: 23291597
[TBL] [Abstract][Full Text] [Related]
4. The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells.
Lee SY; Goverman JM
J Immunol; 2013 May; 190(10):4991-9. PubMed ID: 23562810
[TBL] [Abstract][Full Text] [Related]
5. Myelin basic protein-specific T lymphocytes induce chronic relapsing experimental autoimmune encephalomyelitis in lymphocyte-deficient (SCID) mice.
Jones RE; Mass M; Bourdette DN
J Neuroimmunol; 1999 Jan; 93(1-2):92-101. PubMed ID: 10378872
[TBL] [Abstract][Full Text] [Related]
6. Myelin-specific CD8+ T cells exacerbate brain inflammation in CNS autoimmunity.
Wagner CA; Roqué PJ; Mileur TR; Liggitt D; Goverman JM
J Clin Invest; 2020 Jan; 130(1):203-213. PubMed ID: 31573979
[TBL] [Abstract][Full Text] [Related]
7. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A
Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237
[TBL] [Abstract][Full Text] [Related]
8. Experimental autoimmune encephalomyelitis mediated by CD8+ T cells.
Ji Q; Goverman J
Ann N Y Acad Sci; 2007 Apr; 1103():157-66. PubMed ID: 17376824
[TBL] [Abstract][Full Text] [Related]
9. CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis.
Carboni S; Aboul-Enein F; Waltzinger C; Killeen N; Lassmann H; Peña-Rossi C
J Neuroimmunol; 2003 Dec; 145(1-2):1-11. PubMed ID: 14644025
[TBL] [Abstract][Full Text] [Related]
10. Relapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells.
Sasaki K; Bean A; Shah S; Schutten E; Huseby PG; Peters B; Shen ZT; Vanguri V; Liggitt D; Huseby ES
J Immunol; 2014 Apr; 192(7):3029-42. PubMed ID: 24591371
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies.
Stinissen P; Raus J; Zhang J
Crit Rev Immunol; 1997; 17(1):33-75. PubMed ID: 9034723
[TBL] [Abstract][Full Text] [Related]
12. Quetiapine, an atypical antipsychotic, is protective against autoimmune-mediated demyelination by inhibiting effector T cell proliferation.
Mei F; Guo S; He Y; Wang L; Wang H; Niu J; Kong J; Li X; Wu Y; Xiao L
PLoS One; 2012; 7(8):e42746. PubMed ID: 22912731
[TBL] [Abstract][Full Text] [Related]
13. The role of CD8(+) T cells in a model of multiple sclerosis induced with recombinant myelin oligodendrocyte glycoprotein.
Sajic M; Gregson N; Linington C; Hughes RA; Smith KJ
Mult Scler; 2012 Mar; 18(3):286-98. PubMed ID: 21952095
[TBL] [Abstract][Full Text] [Related]
14. Cross-recognition of a myelin peptide by CD8+ T cells in the CNS is not sufficient to promote neuronal damage.
Reuter E; Gollan R; Grohmann N; Paterka M; Salmon H; Birkenstock J; Richers S; Leuenberger T; Brandt AU; Kuhlmann T; Zipp F; Siffrin V
J Neurosci; 2015 Mar; 35(12):4837-50. PubMed ID: 25810515
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis.
Murray PD; McGavern DB; Sathornsumetee S; Rodriguez M
Brain; 2001 Jul; 124(Pt 7):1403-16. PubMed ID: 11408335
[TBL] [Abstract][Full Text] [Related]
16. Characterization of myelin oligodendrocyte glycoprotein (MOG)35-55-specific CD8+ T cells in experimental autoimmune encephalomyelitis.
Peng Y; Zhu FZ; Chen ZX; Zhou JX; Gan L; Yang SS; Gao S; Liu QQ
Chin Med J (Engl); 2019 Dec; 132(24):2934-2940. PubMed ID: 31855963
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms regulating regional localization of inflammation during CNS autoimmunity.
Pierson E; Simmons SB; Castelli L; Goverman JM
Immunol Rev; 2012 Jul; 248(1):205-15. PubMed ID: 22725963
[TBL] [Abstract][Full Text] [Related]
18. NKG2D and Its Ligand MULT1 Contribute to Disease Progression in a Mouse Model of Multiple Sclerosis.
Legroux L; Moratalla AC; Laurent C; Deblois G; Verstraeten SL; Arbour N
Front Immunol; 2019; 10():154. PubMed ID: 30787931
[TBL] [Abstract][Full Text] [Related]
19. CNS-resident classical DCs play a critical role in CNS autoimmune disease.
Giles DA; Duncker PC; Wilkinson NM; Washnock-Schmid JM; Segal BM
J Clin Invest; 2018 Dec; 128(12):5322-5334. PubMed ID: 30226829
[TBL] [Abstract][Full Text] [Related]
20. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
